Free Trial
NYSEMKT:PHGE

BiomX (PHGE) Stock Price, News & Analysis

BiomX logo
$0.54 -0.20 (-27.20%)
As of 03:42 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About BiomX Stock (NYSEMKT:PHGE)

Key Stats

Today's Range
$0.72
$0.78
50-Day Range
$0.39
$0.59
52-Week Range
$0.34
$2.40
Volume
53,300 shs
Average Volume
347,190 shs
Market Capitalization
$14.28 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$21.00
Consensus Rating
Buy

Company Overview

BiomX Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
41st Percentile Overall Score

PHGE MarketRank™: 

BiomX scored higher than 41% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    BiomX has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    BiomX has received no research coverage in the past 90 days.

  • Read more about BiomX's stock forecast and price target.
  • Earnings Growth

    Earnings for BiomX are expected to grow in the coming year, from ($0.44) to ($0.36) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of BiomX is -0.73, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of BiomX is -0.73, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    BiomX has a P/B Ratio of 0.76. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Short Interest

    There is no current short interest data available for PHGE.
  • Dividend Yield

    BiomX does not currently pay a dividend.

  • Dividend Growth

    BiomX does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for PHGE.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for BiomX this week, compared to 0 articles on an average week.
  • Search Interest

    8 people have searched for PHGE on MarketBeat in the last 30 days. This is an increase of 700% compared to the previous 30 days.
  • MarketBeat Follows

    2 people have added BiomX to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, BiomX insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 1.17% of the stock of BiomX is held by insiders.

  • Percentage Held by Institutions

    40.57% of the stock of BiomX is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about BiomX's insider trading history.
Receive PHGE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BiomX and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

PHGE Stock News Headlines

BiomX (NYSEMKT:PHGE) Stock Price Down 25.4% - What's Next?
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.tc pixel
BiomX Inc. (PHGE) Q2 2025 Earnings Call Transcript
What to Expect from BiomX's Earnings
See More Headlines

PHGE Stock Analysis - Frequently Asked Questions

BiomX's stock was trading at $0.7301 at the beginning of 2025. Since then, PHGE stock has decreased by 27.1% and is now trading at $0.5320.

BiomX Inc. (NYSEMKT:PHGE) posted its quarterly earnings results on Monday, May, 15th. The company reported ($2.00) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($1.80) by $0.20.

BiomX shares reverse split before market open on Monday, August 26th 2024.The 1-10 reverse split was announced on Thursday, August 15th 2024. The number of shares owned by shareholders was adjusted after the market closes on Friday, August 23rd 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Top institutional investors of BiomX include Warberg Asset Management LLC (0.31%). Insiders that own company stock include Israel Biofund Gp Limi Orbimed, Chidozie Ugwumba and Assaf Oron.
View institutional ownership trends
.

Shares of PHGE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that BiomX investors own include Predictive Oncology (POAI), JPMorgan Chase & Co. (JPM), Abbott Laboratories (ABT), NVIDIA (NVDA), Zomedica (ZOM), Insulet (PODD) and Ford Motor (F).

Company Calendar

Last Earnings
5/15/2023
Today
8/29/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSEMKT
Sector
Medical
Industry
Biotechnology
Sub-Industry
Pharmaceutical Products
Current Symbol
NYSEMKT:PHGE
CIK
1739174
Fax
N/A
Employees
120
Year Founded
N/A

Price Target and Rating

High Price Target
$21.00
Low Price Target
$21.00
Potential Upside/Downside
+3,690.6%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

EPS (Trailing Twelve Months)
($1.36)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$28.32 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-127.82%
Return on Assets
-56.50%

Debt

Debt-to-Equity Ratio
0.51
Current Ratio
2.84
Quick Ratio
2.84

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.70 per share
Price / Book
0.79

Miscellaneous

Outstanding Shares
26,534,000
Free Float
44,044,000
Market Cap
$14.70 million
Optionable
Not Optionable
Beta
1.42
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NYSEMKT:PHGE) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners